MedPath

Metabolic effects of Diabecinn (oral cinnamon extract) in diabetes type 2, a placebo-controlled randomized clinical trial.

Suspended
Conditions
Type 2 diabetes
Registration Number
NL-OMON28157
Lead Sponsor
OTC Pharma
Brief Summary

/A

Detailed Description

Not available

Recruitment & Eligibility

Status
Suspended
Sex
Not specified
Target Recruitment
120
Inclusion Criteria

1. Type 2 diabetes patients;

2. Age 35-70 years inclusive;

Exclusion Criteria

1. Pregnancy;

2. Breast-feeding.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
HbA1c.
Secondary Outcome Measures
NameTimeMethod
1. Lipid profile;<br /><br>2. 6 point glucose profile;<br /><br>3. Hypoglycemia;<br /><br>4. Body weight;<br /><br>5. Free fatty acids;<br /><br>6. CRP.<br />
© Copyright 2025. All Rights Reserved by MedPath